TSPT: Profile for Transcept Pharmaceuticals, Inc.

Transcept Pharmaceuticals, Inc.
1003 West Cutting Boulevard
Suite 110 Pt. Richmond
Richmond, CA 94804
United States - Map
Phone: 510-215-3500
Fax: 510-215-3535
Web Site: http://www.transcept.com

DETAILS

Index Membership:	N/A
Sector:	Healthcare
Industry:	Biotechnology
Full Time Employees:	N/A

BUSINESS SUMMARY

Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of proprietary products that address therapeutic needs in the field of neuroscience. Its lead product candidate, Intermezzo, a sublingual low dose formulation of zolpidem used for sleep aid has completed Phase III clinical trial. The company is headquartered in Point Richmond, California.

Key Statistics

COMPANY WEBSITES

Home Page

Search Yahoo! for:
More on Transcept Pharmaceuticals, Inc.

CORPORATE GOVERNANCE

Transcept Pharmaceuticals, Inc.'s Corporate Governance Quotient (CGQ®) as of 1-Dec-09 is better than 53.5% of CGQ Universe companies and 28.9% of Pharmaceuticals, Biotechnology & Life Sciences companies.

Brought to you by Institutional Shareholder Services.

View Financials

KEY EXECUTIVES

	Pay	Exercised
Mr. Glenn A. Oclassen Sr., 66 Chief Exec. Officer, Pres	$ 478.00K	N/A
Mr. Thomas P. Soloway , 42 Chief Financial Officer and Sr. VP of Operations	$ 307.00K	N/A
Dr. Nikhilesh N. Singh Ph.D, 51 Chief Scientific Officer and Sr. VP	$ 306.00K	N/A
Ms. Marilyn E. Wortzman CPA, 62 Principal Accounting Officer and VP of Fin.	$ 253.00K	N/A
Mr. Terrence O. Moore , 55 VP of Marketing & Sales	$ 179.00K	N/A

Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.

View Insiders

Add to Portfolio

Set Alert

Email to a Friend

•

Annual Reports

•

Sector Analysis